Dr. Akum Sandra
ActiveDr. Akum Sandra has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €38k and a net result of €36k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 87% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
98
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3.5k at 30 days acceptable
Liquidity ample (current ratio 13.59 against 50.87 in 2024; short-term debt: 7.4% and cash: 41% of total assets), and 7.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
92.6%
Return on assets
87.7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
31 d early
2024
on the day
2023
13 d early
2022
7 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€38k▼ 69.0%
2024 · €121k
2022: €10k
2023: €65k
2024: €121k
2022 → 2025
Total assets
€41k▼ 67.2%
2024 · €124k
2022: €10k
2023: €66k
2024: €124k
2022 → 2025
Net result
€36k▼ 36.8%
2024 · €56k
2022: €10k
2023: €53k
2024: €56k
2022 → 2025
Working capital
€38k▼ 68.5%
2024 · €119k
2022: €7k
2023: €63k
2024: €119k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€10k-€65k▲ 563%€121k▲ 86.9%€38k▼ 69.0%
Operating result€12k-€67k▲ 437%€70k▲ 5.0%€45k▼ 36.0%
Net result€10k-€53k▲ 442%€56k▲ 6.2%€36k▼ 36.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 36% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €41k
Equity
€38k▼ 69.0%
Debt
€3k▲ 24.7%
The debt ratio rises from 1.9% to 7.4%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€47k▼
2024 · €72k
Cash flow
€37k▼
2024 · €58k
Solvency
92.6%▼
2024 · 98.1%
Current ratio
13.59▼
2024 · 50.87
Quick ratio
13.59▼
2024 · 50.87
Debt / equity
0.08▲
2024 · 0.02
ROE
94.7%▲
2024 · 46.5%
ROA
87.7%▲
2024 · 45.6%
Interest coverage
827.46▲
2024 · 175.20
Debt
€3k▲
2024 · €2k
Debt ≤ 1 year
€3k▲
2024 · €2k
Income taxes
€10k▼
2024 · €15k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€124k€41k▼
Formation expenses20€1k-
Fixed assets21/28€803-
Tangible fixed assets22/27€803-
Furniture and vehicles24€803-
Current assets29/58€122k€41k▼
Amounts receivable after more than one year29€58k-
Other amounts receivable291€58k-
Amounts receivable within one year40/41€21k€23k▲
Trade receivables40€14k€11k▼
Other amounts receivable41€7k€12k▲
Cash at bank and in hand54/58€41k€17k▼
Deferred charges and accrued income490/1€778€658▼
Equity and liabilities
Total equity and liabilities10/49€124k€41k▼
Equity10/15€121k€38k▼
Contributions10/11€2k€2k=
Reserves13€119k€36k▼
Distributable reserves133€119k€36k▼
Amounts payable17/49€2k€3k▲
Amounts payable within one year42/48€2k€3k▲
Trade debts44€1k€245▼
Suppliers440/4€1k€245▼
Taxes, remuneration and social security45€1k€3k▲
Taxes450/3€1k€3k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€2k▲
Other operating charges640/8€190€515▲
Gross operating margin9900€72k€47k▼
Operating profit (loss)9901€70k€45k▼
Financial income75/76B€2k€174▼
Recurring financial income75€2k€174▼
Financial charges65/66B€409€57▼
Recurring financial charges65€409€57▼
Profit (loss) for the period before taxes9903€71k€45k▼
Income taxes67/77€15k€10k▼
Profit (loss) for the period9904€56k€36k▼
Profit (loss) for the period to be appropriated9905€56k€36k▼
Appropriation of the result
Profit (loss) to be appropriated9906€56k€36k▼
Transfer from equity791/2-€119k
Transfer to equity691/2€56k€36k▼
To other reserves6921€56k€36k▼
Profit to be distributed694/7-€119k
Return on contributions (dividend)694-€119k
The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2022net €56k ▲6.2%
Operating result €70k, net result €56k, both a record.
31-12
Financial
Equity above €100kEq €121k ▲86.9%
3 profitable years in a row build equity to €121k.
18-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
07-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 7 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Turnhout · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Tingietersstraat 22300 TurnhoutGround area
974 m²
Building footprint
210 m²
Volume, LiDAR
818 m³
Parcel 13452M0442/00D000, Flanders · tallest building 7.0 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Dr Akum Sandra
since 20222.335.757.426
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13452M0442/00D000 | Flanders | 974 m² | 1 · 210 m² | 7.0 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
9845004D02FC7CGI3909
Similar companies · same sector, comparable size
Verhasselt Lies, Huisarts
BE 0750.715.365
Ternat · Eq €38k
DR.KHALID KHAN, HUISARTS
BE 0761.627.073
Gent · Eq €38k
BOUDA MEDIC
BE 0599.992.906
Rixensart · Eq €37k
Dr. Nelly Vandewalle
BE 0779.350.755
Harelbeke · Eq €38k
Dacy Médi Care
BE 1005.046.791
Sint-Lambrechts-Woluwe · Eq €37k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 4,192 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded20-09-2022
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.